Sentence examples for model when assessing from inspiring English sources

The Matérn variogram should therefore be used rather than the exponential model when assessing the adequacy of a variogram estimate.

This suggests that measures of demand using the exponential demand model may be more sensitive than measures using the linear-elasticity model when assessing small changes in reward value.

According to the model, when assessing whether someone intentionally brings about some state of affairs, people determine (typically unconsciously) whether there exists sufficient concordance between their representation of the outcome the agent brings about and what they take to be her deep self.

Wound classification was additionally adjusted for in the model when assessing the mediation effect of SSI.

The apparent calibration intercept and slope were ideal for standard model when assessing the overall performance, and ideal for the marginal risk calculation when assessing the within cluster performance.

This more quantitative use of the comorbidity index, as opposed to simply measuring presence versus absence of any comorbidity, might provide a more clinically-useful model when assessing the role of a comorbidity index on the diagnosis, treatment, and outcomes of cancer.

The vegetation transition probability model was marginally more accurate than the rule-based model when assessed on a cell-by-cell basis, but the rule-based model replicated the spatial distribution of vegetation communities more accurately and may be more broadly applicable.

These restrictions complicate the use of such models when assessing the distribution of industrial emissions in the atmosphere.

We recommend the use of natural marine bacteria as models when assessing the environmental relevant antibacterial properties of products containing nanosilver.

Also, although some regulatory agencies suggest that researchers consider using middle and low doses for rodent carcinogenicity studies (e.g., the FDA), we recommend that agencies require researchers to use non-linear dose response models when assessing the carcinogenicity of drugs.

The difference in incremental QALY gain between the CS and VA models when assessing the cost effectiveness of anti-VEGF therapy is potentially significant in healthcare decision making, particularly in decisions close to the cost-effectiveness threshold.